EY Pulse of the Industry Medical Technology Report 2023
Every year, the medtech industry looks to the EY Pulse of the Industry Report to shed light on the recent developments and trends impacting our work and patient care. The 17th edition of this report breaks down the enormous promises of AI in supply chain optimization, workforce transformation, remote care and so many other vital areas –while providing a closer look at the data around medtech’s financing picture and financial performance in 2022 and early 2023.
Related Reading
News / Global & Trade
AdvaMed Statement on FDA-USAID India Regulatory Session
April 16, 2024
AdvaMed, the Medtech Association, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring medical technology reaches patients. The event, called “Minds to Markets: Regulatory Considerations in Med-Tech,” advances US-India cooperation on medtech supply chain through greater regulatory alignment.
News / Global & Trade
AdvaMed Statement on the World Trade Organization Ministerial Conference
March 1, 2024
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker regarding the conclusion of the World Trade Organization Ministerial conference in Abu Dhabi.
News / Global & Trade / Medical Imaging
AdvaMed Statement on the Sale and Privatization of the Federal Helium Reserve
January 22, 2024
Scott Whitaker, President and CEO of AdvaMed, the Medtech Association, urged the White House to delay the sale and privatization of the Federal Helium Reserve until concerns about resulting supply chain disruptions are resolved.
News / Global & Trade
AdvaMed Statement on 14th Ministerial Meeting of the United States-India Trade Policy Forum
January 19, 2024
AdvaMed President and CEO Scott Whitaker released the following statement regarding the 14th Ministerial-level Trade Policy Forum held in New Delhi, India:
News / Global & Trade / Supply Chain
AdvaMed Commends Administration Investment in Domestic Semiconductor Chip Manufacturing
January 10, 2024
The investments being made in our domestic semiconductor chip manufacturing base under the CHIPS and Science Act are critical for the medtech industry and the millions of patients who rely on the life-saving devices the medtech industry develops.
Global & Trade
Relief Response
In times of crisis, the medtech industry stands as a pillar of strength, providing innovative solutions to address immediate needs and foster resilience. Discover a few NGOs that AdvaMed members can partner with to help make a positive impact around the world.
News / Government & Legislative Affairs / Supply Chain
ICYMI: AdvaMed Calls for Greater Federal Prioritization of Medtech
January 4, 2024
In a new op-ed in RealClear Health, AdvaMed President and CEO Scott Whitaker called on the Biden Administration to ensure the medtech industry is considered as it implements policies to strengthen domestic supply chains.
News / Supply Chain
AdvaMed Applauds Biden Administration Efforts to Strengthen Supply Chains, Protect Patients
November 28, 2023
Today, AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the recent actions to strengthen supply chains announced by President Biden as part of the inaugural convening of the White House Council on Supply Chain Resilience: